Clinical Trial Update: Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate Asthma [NA]

View source ↗

Summary

The clinical trial assessing the effect of inhaled fluticasone propionate on bone metabolism in patients with mild to moderate asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: University of Kansas | Conditions: Asthma | NA | Status: WITHDRAWN